|
|
|
|
|
|
|
|
|
|
|
| Category |
Health: Pharmacy
|
|
| Category 2 |
Science: Chemistry
|
|
| Category 3 |
Science: Biotechnology
|
|
|
|
|
|
|
|
|
|
| Description |
This is a forward thinking event focusing on the practical implementation of cardiac safety testing programmes based on feedback from completed Thorough QT Trials. Clarification of the regulations in light of the developments of E14 over the last year, along with a strong focus on the CRO market and outsourcing strategies, optimising preclinical trials and perfecting the methodological approaches will allow you to implement an effective and thorough cardiac safety testing programme that extends beyond E14.
|
|
|
|
